Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, 416.8 mL recall — Central Admixture Pharmacy Services Inc (Class III)

Central Admixture Pharmacy Services Inc is recorded by the U.S. Food and Drug Administration (FDA) as recalling Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, 416.8 mL — a Class III recall, initiated 2026-07-16 and posted to the FDA enforcement report on 2026-08-12, under recall number D-0740-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Incorrect Product Formulation”. From the product description, the form is injection, the strength given is 416.8 mL and it is marked Rx only. Distribution is recorded as “GA only” — Limited / regional distribution, with the recalling firm on record in GA, United States. It is the only recall number the FDA has filed under event ID 99535. Central Admixture Pharmacy Services Inc accounts for 2 recall records in the indexed dataset. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0740-2026
FDA event ID 99535
Classification Class III (least serious regulatory tier)
Status Ongoing
Recalling firm Central Admixture Pharmacy Services Inc
Recall initiated 2026-07-16
Reported by FDA 2026-08-12
Report lag 27 days from initiation to report
Distribution GA only — Limited / regional distribution
Firm location on record GA, United States
Product description (source) Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., Atlanta, 1750 Corp Dr. Ste 725, Norcross, GA 30093 (844) 903-6418

Reason reported by FDA

Incorrect Product Formulation

3 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

3 identifying values matched by exact pattern in the 40-word product description above; each is a literal substring of it.

Product named Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag
Form Injection
Strength 416.8 mL
Marketing category Rx only

Other indexed recalls from Central Admixture Pharmacy Services Inc

2 indexed records name Central Admixture Pharmacy Services Inc as the recalling firm, across 2 FDA events, reported 2026-07-01 to 2026-08-12. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, 1295 mLD-0618-2026Class II1295 mL · Injection2026-07-01

Reported in the same month (2026-08)

11 enforcement reports carry a report date in 2026-08; these 3 are the Class III ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Dabigatran Etexilate Capsules, 150 mgD-0737-2026Ascend Laboratories, LLCClass III2026-08-05
Dabigatran Etexilate Capsules, 75 mgD-0738-2026Ascend Laboratories, LLCClass III2026-08-05
Dabigatran Etexilate Capsules, 75 mgD-0739-2026Ascend Laboratories, LLCClass III2026-08-05

Nearest Class III recalls by date

25 of 250 indexed records share the Class III tier; the 10 nearest to 2026-08-12 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Lidolog Kit, 2%D-0713-2026Asclemed Usa Inc.2% · Injection2026-07-29
Dabigatran etexilate Capsules, 110 mgD-0735-2026Ascend Laboratories, LLC110 mg · Capsules2026-07-29
Dabigatran etexilate Capsules, 150 mgD-0736-2026Ascend Laboratories, LLC150 mg · Capsules2026-07-29
Fexofenadine Hydrochloride Tablets, 180 mgD-0654-2026Sun Pharmaceutical Industries Inc180 mg · Tablets2026-07-08
hydrOXYzine Hydrochloride Oral Solution, 10 mg/5 mLD-0619-2026Ani Pharmaceuticals, Inc.10 mg/5 mL · Oral Solution2026-07-01
Focalin XR (dexmethylphenidate HCl) 5 mgD-0608-2026Sandoz Inc5 mg · Extended-Release Capsules2026-06-24
Epinephrine Injection, 1mg/mLD-0581-2026Fresenius Kabi Usa, LLC1mg/mL · Injection2026-06-17
Primidone Tablets, 50 mgD-0585-2026Amneal Pharmaceuticals, LLC50 mg · Tablets2026-06-17
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLC2% · Injection2026-06-10
Nicotine Transdermal System Patch, 14 mgD-0550-2026Aveva Drug Delivery Systems, Inc.14 mg · Transdermal System2026-06-03

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Central Admixture Pharmacy Services Inc (2 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0740-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0740-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-08-12
Ingested
2026-08-22
Record hash
7351d6986f0c2a58

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.